Progression on the Multiple Sclerosis Functional Composite in multiple sclerosis: what is the optimal cut-off for the three components?

被引:42
|
作者
Bosma, L. V. A. E. [1 ]
Kragt, J. J. [1 ]
Brieva, L. [2 ]
Khaleeli, Z. [3 ]
Montalban, X. [2 ]
Polman, C. H. [1 ]
Thompson, A. J. [3 ]
Tintore, M. [2 ]
Uitdehaag, B. M. J. [1 ,4 ]
机构
[1] Vrije Univ Amsterdam Med Ctr, Dept Neurol, NL-1007 MB Amsterdam, Netherlands
[2] Hosp Univ Vall Hebron, Unitat Neuroimmunol Clin, Barcelona, Spain
[3] UCL, Dept Brain Repair & Rehabil, Inst Neurol, London, England
[4] Vrije Univ Amsterdam Med Ctr, Dept Clin Epidemiol & Biostat, NL-1007 MB Amsterdam, Netherlands
关键词
9-Hole Peg Test; multiple sclerosis; Multiple Sclerosis Functional Composite; outcome measurement; Paced Auditory Serial Addition Test; primary progressive; Timed 25-Foot Walk; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; INTERFERON BETA-1A; OUTCOME MEASURE; RELIABLE CHANGE; CLINICAL-TRIAL; MS; MULTICENTER; DISABILITY; NATALIZUMAB;
D O I
10.1177/1352458510370464
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
For the Timed 25-Foot Walk (T25FW) and 9-Hole Peg Test (9HPT), components of the Multiple Sclerosis Functional Composite (MSFC), cut-off points of 20% change have previously been defined as meaningful endpoints of functional decline. Recently, however, a 15% change of MSFC components was introduced. The objective of this study was to determine optimal cut-offs for all MSFC components to indicate clinical disease progression in a primary progressive (PP) multiple sclerosis (MS) population. T25FW, 9HPT and the Paced Auditory Serial Addition Test (PASAT) were performed in 161 patients with PPMS with a 2-year interval. Absolute and relative differences in test scores were calculated. For each cut-off point of relative change, proportions of patients who progressed (deterioration beyond cut-off value) and improved (improvement beyond cut-off value) were calculated. Further, we calculated the ratio of 'improved' versus 'progressed' patients. Line graphs were created indicating: percentage progressed patients, percentage improved patients, and ratio of improved versus progressed patients. The optimal cut-off was determined by searching the cutoff point with the lowest ratio of improved versus progressed patients, while at the same time capturing a substantial amount of progression. For both T25FW and 9HPT, the ratio between patients that improved and worsened clearly decreased between the cut-offs of 15% and 20%. For the PASAT, the ratio between patients improved and worsened was persistently poor. In conclusion, a cut-off of 20% for both T25FW and 9HPT has a better signal-to-noise ratio than lower values (e.g. 15%) and is therefore preferable for the assessment of disease progression. No satisfactory cut-off point for the PASAT could be determined.
引用
收藏
页码:862 / 867
页数:6
相关论文
共 50 条
  • [1] Progression on the multiple sclerosis functional composite in primary progressive multiple sclerosis: what is the optimal cut-off on the three test components?
    Bosma, L.
    Kragt, J.
    Brieva, L.
    Khaleeli, Z.
    Montalban, X.
    Polman, C. H.
    Thompson, A. J.
    Tintore, M.
    Uitdehaag, B.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S6 - S7
  • [2] Age cut-off for cognitive evaluation of multiple sclerosis patients
    Naseri, Amirreza
    Seyedi-Sahebari, Sepideh
    Talebi, Mahnaz
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [3] Gait tests in multiple sclerosis: Reliability and cut-off values
    Decavel, Pierre
    Moulin, Thierry
    Sagawa, Yoshimasa, Jr.
    GAIT & POSTURE, 2019, 67 : 37 - 42
  • [4] Brief international cognitive assessment for multiple sclerosis (BICAMS) cut-off scores for detecting cognitive impairment in multiple sclerosis
    Artemiadis, Artemios
    Bakirtzis, Christos
    Chatzittofis, Andreas
    Christodoulides, Constantinos
    Nikolaou, George
    Boziki, Marina Kleopatra
    Grigoriadis, Nikolaos
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 49
  • [5] Assessing disability progression with the Multiple Sclerosis Functional Composite
    Rudick, R. A.
    Polman, C. H.
    Cohen, J. A.
    Walton, M. K.
    Miller, A. E.
    Confavreux, C.
    Lublin, F. D.
    Hutchinson, M.
    O'Connor, P. W.
    Schwid, S. R.
    Balcer, L. J.
    Lynn, F.
    Panzara, M. A.
    Sandrock, A. W.
    MULTIPLE SCLEROSIS JOURNAL, 2009, 15 (08) : 984 - 997
  • [6] The multiple sclerosis functional composite: different practice effects in the three test components
    Solari, A
    Radice, D
    Manneschi, L
    Motti, L
    Montanari, E
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 228 (01) : 71 - 74
  • [7] Optimal reference population for the multiple sclerosis functional composite
    Fox, R. J.
    Lee, J-C
    Rudick, R. A.
    MULTIPLE SCLEROSIS, 2007, 13 (07): : 909 - 914
  • [8] Multiple sclerosis functional composite predicts thalamic atrophy in multiple sclerosis
    Capuano, Rocco
    Bisecco, Alvino
    D'Ambrosio, Alessandro
    Altieri, Manuela
    Docimo, Renato
    Cirillo, Mario
    Trojsi, Francesca
    Russo, Antonio
    Marzi, Chiara
    Diciotti, Stefano
    Tedeschi, Gioacchino
    Gallo, Antonio
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [9] The Multiple Sclerosis Functional Composite: a new clinical outcome measure for multiple sclerosis
    Rudick, RA
    Cutter, G
    Reinold, S
    MULTIPLE SCLEROSIS, 2002, 8 (05): : 359 - 365
  • [10] Measuring sustained disability progression using the multiple sclerosis functional composite
    Hutchinson, M.
    Polman, C. H.
    Rudick, R. A.
    Balcer, L. J.
    Cohen, J. A.
    Confavreux, C.
    Lublin, F. D.
    Miller, A.
    O'Connor, P. W.
    Schwid, S. R.
    Lynn, F.
    Panzara, M. A.
    Sandrock, A. W.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 21 - 21